Tag: immunology

Eli Lilly completes $2.4bn acquisition of DICE Therapeutics

businessnewstoday- August 10, 2023

Eli Lilly and Company (Lilly) has finalized its acquisition of DICE Therapeutics, Inc. (NASDAQ: DICE) for $2.4 billion, bolstering its immunology portfolio with the inclusion ... Read More

AbbVie, Calibr to drive preclinical and clinical advancements in expanded partnership

businessnewstoday- July 26, 2023

AbbVie and Scripps Research institute’s division Calibr have announced a broadened strategic collaboration targeted at developing preclinical and early-stage clinical assets across a host of ... Read More

Acelyrin boosts immunology pipeline through acquisition of ValenzaBio

Raghuram Kadari- January 7, 2023

Acelyrin has acquired ValenzaBio, a privately held clinical-stage biopharmaceutical company, in an all-stock deal. With the acquisition of ValenzaBio, the US- based late-stage clinical biopharma ... Read More

Grifols to acquire German healthcare company Biotest for €1.6bn

pallavi123- September 19, 2021

Spanish pharma company Grifols has agreed to acquire Tiancheng (Germany) Pharmaceutical, which holds nearly 90% stake of German publicly listed healthcare company Biotest. The deal ... Read More